Birdwatch Note Rating
2023-04-03 22:27:53 UTC - HELPFUL
Rated by Participant: B289B7B9A72A2B21A5016714B5CFECC892B67D4EF528AD49D229201250F7B83A
Participant Details
Original Note:
Three doses of BNT162b2 have a vaccine effectiveness of 73.5% against mild or moderate disease in adults aged 20–59 years, 98.6% protection against severe disease https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00345-0/fulltext#tbl2 The 3-dose VE against hospitalization was 97.5%, 82.0%, and 72.4%, respectively. https://www.medrxiv.org/content/10.1101/2022.09.30.22280573v2
All Note Details